AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
InfuSystem Holdings, Inc.
Video analysis: INFU
All videosNo video analysis for this stock yet. Request one from our team.
News: INFU
BlackRock Inc. Takes Position in InfuSystem Holdings, Inc. $INFU
BlackRock Inc. bought a new position in shares of InfuSystem Holdings, Inc. (NYSE: INFU) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,585,415 shares of the company's stock, valued at approximately $15,299,000. BlackRock Inc. owned approximately 7.86% of InfuSystem
InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript
InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.12 per share a year ago.
InfuSystem Announces Financial Results for Second Quarter 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Second Quarter 2026.
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026.
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InfuSystems Holdings (INFU) Soars 11.1%: Is Further Upside Left in the Stock?
InfuSystems Holdings (INFU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
InfuSystem: A Good Time To Buy Before A Potential Breakout
InfuSystem is rated a buy, leveraging a stable oncology-focused patient services segment with strong FCF yields, margin progress, and reasonable valuations. INFU offers an attractive FCF yield of 11.6%, nearly double its peer Viemed Healthcare, and trades at a reasonable forward EV/EBITDA multiple below 6.5x. Management's future financial outlook is supported by reduced Capex, ERP-driven efficiencies, and growth in low-capital-intensive segments like wound care.
